A critical discovery in cancer research is emerging with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several forms of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research